Dare Bioscience, Inc. - COM NEW (DARE)

Q1 2025 13F Holders as of 3/31/2025

Type / Class
Equity / COM NEW
Number of holders
24
Total 13F shares, excl. options
827K
Shares change
+49.8K
Total reported value, excl. options
$2.39M
Value change
+$140K
Number of buys
8
Number of sells
-4
Price
$2.89

Significant Holders of Dare Bioscience, Inc. - COM NEW (DARE) as of Q1 2025

25 filings reported holding DARE - Dare Bioscience, Inc. - COM NEW as of Q1 2025.
Dare Bioscience, Inc. - COM NEW (DARE) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 827K shares .
Largest 10 shareholders include VANGUARD GROUP INC (328K shares), AMH Equity Ltd (164K shares), GEODE CAPITAL MANAGEMENT, LLC (95.9K shares), RENAISSANCE TECHNOLOGIES LLC (70.6K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (58.2K shares), STATE STREET CORP (23.5K shares), UBS Group AG (22.1K shares), BlackRock, Inc. (17K shares), COMMONWEALTH EQUITY SERVICES, LLC (16.7K shares), and NORTHERN TRUST CORP (15K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.